Goodpasture syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Akshun Kalia (talk | contribs) No edit summary |
Akshun Kalia (talk | contribs) No edit summary |
||
Line 12: | Line 12: | ||
===Prevalence=== | ===Prevalence=== | ||
*The prevalence of Goodpasture syndrome is estimated to be 1 per million individuals annually. | *The prevalence of Goodpasture syndrome is estimated to be 1 per million individuals annually. | ||
===Age=== | ===Age=== | ||
Goodpasture syndrome occurs in two age peaks | *Goodpasture syndrome occurs in two age peaks.<ref name="pmid21769105">{{cite journal| author=Cui Z, Zhao MH| title=Advances in human antiglomerular basement membrane disease. | journal=Nat Rev Nephrol | year= 2011 | volume= 7 | issue= 12 | pages= 697-705 | pmid=21769105 | doi=10.1038/nrneph.2011.89 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21769105 }} </ref> | ||
*The early onset Goodpasture syndrome is seen with individuals in the age group of 20 and 30. | |||
*The late onset Goodpasture syndrome is seen with individuals in the age group of 60 to 70. | |||
===Gender=== | ===Gender=== | ||
*Goodpasture syndrome affects men and women equally.<ref name="pmid21769105">{{cite journal| author=Cui Z, Zhao MH| title=Advances in human antiglomerular basement membrane disease. | journal=Nat Rev Nephrol | year= 2011 | volume= 7 | issue= 12 | pages= 697-705 | pmid=21769105 | doi=10.1038/nrneph.2011.89 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21769105 }} </ref> | |||
*Males are at increased risk of developing Goodpasture syndrome in the second and third decade. | |||
*Females are at an increased risk of developing the syndrome in the sixth to seventh decade. | |||
===Race=== | ===Race=== | ||
Line 30: | Line 29: | ||
===Region=== | ===Region=== | ||
*The majority of Goodpasture syndrome cases are reported in ethnic groups of New Zealand. | *The majority of Goodpasture syndrome cases are reported in ethnic groups of New Zealand. | ||
==References== | ==References== |
Revision as of 02:40, 25 April 2018
Goodpasture syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Goodpasture syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Goodpasture syndrome epidemiology and demographics |
Goodpasture syndrome epidemiology and demographics in the news |
Risk calculators and risk factors for Goodpasture syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]
Overview
The prevalence of Goodpasture syndrome worldwide affects an estimated 1 per million persons, with high prevalence in Caucasians. The peak incidence of the disease occurs between the ages of 20 and 30 and again at 60 and 70. [1]
Epidemiology and Demographics
Incidence
- The incidence of Goodpasture syndrome is approximately 0.18 cases per 100,000 individuals worldwide.[2] The annual incidence of Goodpasture syndrome in Europe is estimated to range from 0.5 to 1 per 1 million persons.[3]
- The incidence of Goodpasture syndrome is around 1 per 2 million persons per year.
Prevalence
- The prevalence of Goodpasture syndrome is estimated to be 1 per million individuals annually.
Age
- Goodpasture syndrome occurs in two age peaks.[1]
- The early onset Goodpasture syndrome is seen with individuals in the age group of 20 and 30.
- The late onset Goodpasture syndrome is seen with individuals in the age group of 60 to 70.
Gender
- Goodpasture syndrome affects men and women equally.[1]
- Males are at increased risk of developing Goodpasture syndrome in the second and third decade.
- Females are at an increased risk of developing the syndrome in the sixth to seventh decade.
Race
- Goodpasture syndrome usually affects individuals of the white race. Black individuals are less likely to develop Goodpasture syndrome.
- In European populations between 0.5-1 case per million individuals are seen every year. It is rarer in non-European populations.
Region
- The majority of Goodpasture syndrome cases are reported in ethnic groups of New Zealand.
References
- ↑ 1.0 1.1 1.2 Cui Z, Zhao MH (2011). "Advances in human antiglomerular basement membrane disease". Nat Rev Nephrol. 7 (12): 697–705. doi:10.1038/nrneph.2011.89. PMID 21769105.
- ↑ Kluth DC, Rees AJ (1999). "Anti-glomerular basement membrane disease". J Am Soc Nephrol. 10 (11): 2446–53. PMID 10541306.
- ↑ Fomegné G, Dratwa M, Wens R, Mesquita M, Van der Straaten M, Vanden Haute K; et al. (2006). "[Goodpasture disease]". Rev Med Brux. 27 (3): 162–6. PMID 16894954.